These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv. Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents. Penta A; Franzblau S; Wan B; Murugesan S Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1. Lu X; Wan B; Franzblau SG; You Q Eur J Med Chem; 2011 Sep; 46(9):3551-63. PubMed ID: 21641695 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration. Dobrikov GM; Valcheva V; Stoilova-Disheva M; Momekov G; Tzvetkova P; Chimov A; Dimitrov V Eur J Med Chem; 2012 Feb; 48():45-56. PubMed ID: 22154833 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, crystal studies, anti-tuberculosis and cytotoxic studies of 1-[(2E)-3-phenylprop-2-enoyl]-1H-benzimidazole derivatives. Kalalbandi VK; Seetharamappa J; Katrahalli U; Bhat KG Eur J Med Chem; 2014 May; 79():194-202. PubMed ID: 24735645 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents. Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines. Nayyar A; Monga V; Malde A; Coutinho E; Jain R Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805 [TBL] [Abstract][Full Text] [Related]
14. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles. Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives. Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives. de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies. Reddy DS; Hosamani KM; Devarajegowda HC Eur J Med Chem; 2015 Aug; 101():705-15. PubMed ID: 26210508 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2. Lu X; Liu X; Wan B; Franzblau SG; Chen L; Zhou C; You Q Eur J Med Chem; 2012 Mar; 49():164-71. PubMed ID: 22264895 [TBL] [Abstract][Full Text] [Related]
19. Novel fluoroquinolones: design, synthesis, and in vivo activity in mice against Mycobacterium tuberculosis H37Rv. Shindikar AV; Viswanathan CL Bioorg Med Chem Lett; 2005 Apr; 15(7):1803-6. PubMed ID: 15780610 [TBL] [Abstract][Full Text] [Related]
20. Quinonoid and phenazine compounds: synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis. Carneiro PF; Pinto Mdo C; Coelho TS; Cavalcanti BC; Pessoa C; de Simone CA; Nunes IK; de Oliveira NM; de Almeida RG; Pinto AV; de Moura KC; da Silva PA; da Silva Júnior EN Eur J Med Chem; 2011 Sep; 46(9):4521-9. PubMed ID: 21820768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]